Business Wire

IFRC-DREF calls on global donors to help the world ‘Stand Tall’ in the face of accelerating humanitarian need - supporting smarter and faster disaster relief


The International Federation of Red Cross and Red Crescent Societies (IFRC) has launched a new campaign to address rapidly escalating climate driven humanitarian crises. It calls on global governments and international donors to support local emergency responders and disaster hit communities - helping them to Stand Tall with smarter and faster humanitarian funding.

This press release features multimedia. View the full release here:

To view this piece of content from, please give your consent at the top of this page.

Stand Tall in the face of disaster with IFRC-DREF Insurance. (Photo: Business Wire)

The IFRC’s Disaster Response Emergency Fund (IFRC-DREF) is the quickest, most efficient and most transparent way of getting funding directly to local National Societies — both before and immediately after a crisis hits. Yet it faces growing pressure to anticipate and respond to multiple, simultaneous and complex crises around the world as a result of climate change.

Today, 3.6 billion people live in areas highly susceptible to climate change. Humanitarian funding needs are growing as more people are adversely impacted by climate-related disasters each year. The signs are hard to ignore: IFRC-DREF funding allocation increased by 75% to meet escalating demands in the first half of 2023 compared to the same period in 2022 - predominately in response to floods and earthquakes.

Shoulder to shoulder - to Stand Tall

The Stand Tall campaign calls on global governments and private donors to stand shoulder to shoulder with local emergency responders and the communities they support. Stand Tall aims to grow the humanitarian funds available to on-the-ground relief organisations from the CHF 64 million (US$73 million) available today to CHF 100 million (US$114 million) by 2025.

Coinciding with COP28, IFRC’s Stand Tall campaign uses a series of visuals to champion the incredible network of donors, volunteers, and impacted communities that make up IFRC-DREF.

Nena Stoiljkovic, Under-Secretary General at IFRC, said: “In the battle against climate change, we have reached a critical juncture – funding needs outstrip supply as communities face more and more devastating impact. Our funding partners for IFRC-DREF enable us to deliver local response with global support.

“We take a moment to celebrate the incredible work and accomplishments of our inspiring network of funding partners and volunteers in impacted communities. We are proud of their determination and collaboration as we strive to prevent and lessen the burden of climate disasters on vulnerable communities. We encourage our partners to keep supporting IFRC-DREF’s action. Together, we will Stand Tall in the face of climate disasters.”

Smarter and faster funding - to those who need it, when they need it

Unlike other humanitarian funding mechanisms, 82% of IFRC-DREF funds go directly to National Societies supporting local action – compared with a global average of just 1.2%. Localised, community-led action is key to ensuring communities are equipped to prepare for, and overcome, devastating crises.

IFRC-DREF is evolving as it works to increase the impact of every donation to the fund. In September 2023, for example, IFRC announced the launch of IFRC-DREF Insurance - a truly innovative way to ensure that funding is always there for those who need it, when they need it. It acts as a back-stop to IFRC-DREF, bringing an additional CHF 20 million (c US $23 million) on stream, triggered during periods of high demand.

In helping to reach the CHF 100 million target by 2025, global governments and private donors can Stand Tall with emergency responders and their communities - saving lives and livelihoods in the face of climate driven disasters.

To learn more about IFRC-DREF and how donors can support its 2025 ambition, visit

About the International Federation of the Red Cross and Red Crescent Societies (IFRC)

IFRC is the world’s largest humanitarian network, comprising 191 National Societies and bringing together more than 16 million volunteers working to save lives, build community resilience, strengthen localisation and promote dignity around the world.

About the IFRC’s Disaster Response Emergency Fund (IFRC-DREF)

Established in 1979, the IFRC-DREF is the quickest, most efficient, and most transparent mechanism for donors to channel global short-term emergency funding directly for local community-based action. While the average of international humanitarian funds directly channelled to local actors every year lies around 1.2% globally, 82% of IFRC-DREF’s allocation is directly transferred to the National Societies. Since its inception, more than 220 million people in crisis worldwide have benefited from IFRC-DREF support.

To view this piece of content from, please give your consent at the top of this page.

Contact information

For more information:
To request an interview, contact:

About Business Wire

Business Wire
Business Wire

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IFF Announces Grant of Employment Inducement Awards1.3.2024 22:15:00 CET | Press release

IFF (NYSE: IFF) today announced the grant of employment inducement awards to J. Erik Fyrwald, IFF Chief Executive Officer and member of the Board of Directors. The Company's Board of Directors approved the employment inducement awards on Jan. 9, 2024, with a grant date of March 1, 2024, as a material inducement to enter into an offer of employment in reliance on the employment inducement award exception to New York Stock Exchange Listing Rule 303A.08 that requires shareholder approval of equity-based compensation plans. Listing Rule 303A.08 requires the public announcement of such an award. The inducement awards will consist of (i) a target award of 68,750 performance share units (with a maximum award of 171,875 performance share units), subject to meeting the applicable performance targets set forth in the award agreement, and (ii) 56,250 restricted stock units, 100% of which will vest on the three-year anniversary of the grant date, for a maximum potential combined payout of 228,125

Whitehorse Liquidity Partners Recognized by Private Equity International’s 2023 Awards1.3.2024 16:30:00 CET | Press release

Whitehorse Liquidity Partners (together with its advisory affiliates, “Whitehorse”), a specialized investment manager focused on providing structured liquidity solutions to the alternative asset class, is pleased to announce recognition from Private Equity International (PEI) in the 2023 PEI Awards. Whitehorse placed third in the Secondaries Firm of the Year in the Americas category alongside Blackstone Strategic Partners and HarbourVest Partners and was voted Firm of the Year in Canada. “We are honoured to have been recognized again in two categories by the PEI Awards,” said Yann Robard, Managing Partner of Whitehorse. “For the fourth time among the top three Secondaries Firm of the Year in the Americas category (2018, 2020, 2022 and 2023) and the sixth time among the top three in the Firm of the Year in Canada category (2017, 2018, 2020, 2021, 2022 and 2023). You often hear us say that big is beautiful, growth is good and scale matters. Our scale has enabled us, not disrupted us. We

Calvin Klein Fragrances announces Idris and Sabrina Elba as the face of new Calvin Klein ETERNITY AROMATIC ESSENCE fragrance campaign1.3.2024 14:30:00 CET | Press release

Calvin Klein, Inc., a wholly owned subsidiary of PVH Corp. (NYSE: PVH), and Calvin Klein Fragrances, a division of Coty Inc. (NYSE: COTY), today unveil actor and musician Idris Elba and his wife, model and human rights activist Sabrina Elba as the faces of Calvin KleinETERNITY AROMATIC ESSENCE, the newest addition to the ETERNITYfragrance portfolio. This press release features multimedia. View the full release here: Calvin Klein Fragrances announces Idris and Sabrina Elba as the face of new Calvin Klein ETERNITY AROMATIC ESSENCE fragrance campaign (Photo: Business Wire) Shot by Mert Alas, the campaign offers a fresh and impactful take on ETERNITY’s timeless dream of eternal love, capturing Idris and Sabrina in moments of intimacy set to a bespoke cover of “Fever” by FKA twigs. The striking campaign imagery is inspired by profound connection and the essence of desire, paying tribute to ETERNITY’s legacy of sensuality by partnerin

Wellness Market Leaders Join Forces: The DRIPBaR Powered by REVIV1.3.2024 13:35:00 CET | Press release

The DRIPBaR, recognized as the fastest-growing IV therapy franchise in the United States, has joined forces with REVIV, the global leader in IV therapy, marking a significant milestone for the industry. The partnership creates an unrivaled offering by bringing together the specialties of two industry heavyweights boasting over 200 locations across 6 continents, with plans to add thousands more locations in the coming years. The recent surge in demand for IV therapy presents enormous opportunities globally for the companies to redefine industry standards and spearhead the next era of IV therapy. This press release features multimedia. View the full release here: Ben Crosbie, CEO of The DRIPBaR and Sarah Lomas, Founder and CEO of REVIV Global, announce their exciting partnership. (Photo: Business Wire) With an extensive pipeline boasting over 450 franchisees in the United States, The DRIPBaR's decision to integrate REVIV's proprie

GENESIS Pharma Announces an Exclusive Distribution Agreement With Regeneron Pharmaceuticals to Commercialize cemiplimab in Greece, Cyprus and Malta1.3.2024 09:37:00 CET | Press release

GENESIS Pharma, a regional biopharma company specialized in the commercialization of innovative medicines targeting severe and rare diseases in Central and Eastern Europe, announces an exclusive distribution agreement for the cancer medicine cemiplimab in Greece, Cyprus and Malta with Regeneron Ireland DAC. Regeneron Ireland DAC is a wholly owned subsidiary of Regeneron, a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Cemiplimab is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells and was invented using Regeneron's proprietary VelocImmune® technology. In the European Union, cemiplimab is indicated for adults as monotherapy treatment for certain patients with locally advanced or metastatic basal cell carcinoma (BCC), as monotherapy treatment for certain patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC), as both monotherapy o

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye